Physician profile
Klane White
NPI 1821037912
$107,001.81
in general payments reported to CMS, 2019-2025
12 companies · $16K in 2025
The $16K reported for 2025 was more than what 94% of Pediatric Orthopaedic Surgery providers received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $17K · 2021: $10K · 2022: $12K · 2023: $8,411 · 2024: $24K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Consulting Fee: $12K · Education: $3,931 · Food and Beverage: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,626.61 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $14,816.00 |
| Consulting Fee | $12,321.40 |
| Education | $3,930.85 |
| Food and Beverage | $1,253.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomarin Pharmaceutical INC. | $90,105.66 | 2019-2025 | Voxzogo 1.2mg, Vimizim |
| Genzyme Corporation | $14,394.73 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $1,615.14 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $504.22 | 2020 | |
| Medical Device Business Services, INC. | $121.49 | 2020 | |
| Medtronic, INC. | $106.79 | 2024-2025 | Mazor X System, O-Arm |
| Orthopediatrics Corp. | $71.00 | 2024 | |
| Stryker Corporation | $30.85 | 2025 | Axsos |
| Nuvasive, INC. | $25.96 | 2019 | |
| Depuy Synthes Sales INC. | $13.03 | 2023 | Expedium |
| Siemens Medical Solutions USA, INC. | $12.94 | 2023 | Multitom Rax |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Klane White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.